Genesis Therapeutics
Genesis Therapeutics is an AI-driven biotechnology company based in Burlingame, California, with a laboratory in San Diego. The company focuses on accelerating drug discovery using advanced machine learning and molecular simulation technologies, specializing in small molecule drug discovery for challenging targets. The core technology of Genesis is the GEMS platform, which integrates generative AI, predictive modeling, and molecular simulations to design and optimize drug candidates. This platform allows for the proposal of novel molecular structures, evaluation of drug-target interactions, and analysis of molecular structures in three dimensions. Genesis operates through an internal pipeline that develops proprietary drug candidates and engages in strategic partnerships with major pharmaceutical companies, including Eli Lilly, Genentech, Gilead Sciences, and Incyte. The company has raised over $300 million from prominent investors, including Andreessen Horowitz and NVIDIA's NVentures, to support its mission of addressing severe health conditions through innovative drug discovery.
Work at Genesis Therapeutics in HR or recruiting? Claim this page
Headcount trend
Genesis Therapeutics went from 72 employees in Oct 2024 to 123 in Sep 2026. Apr to Sep 2026: 22 people joined, 15 left.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Nov 2024 | Venture | – | 1 | |
| Aug 2023 | Series B | $224M | 7 | |
| Jun 2022 | Funding | $23.9M | – | – |
| Dec 2020 | Series A | $52M | 5 | |
| Nov 2019 | Seed | $4.1M | 2 |
Org structure
Headcount by department
H-1B sponsorship
The department split adds up all the years listed above. FY2025 alone: 2 filings.
Peer reviews
Worked with someone at Genesis Therapeutics?
Anonymous peer reviews on OffTheRecord
Similar companies
Genesis Therapeutics FAQ
How many employees does Genesis Therapeutics have?
Genesis Therapeutics has about 123 employees, down 0.8% over the 3 months to Sep 2026.
Does Genesis Therapeutics sponsor H1B visas?
Yes. Genesis Therapeutics filed 2 H1B (LCA) applications in FY2025, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is Genesis Therapeutics's revenue per employee?
Genesis Therapeutics makes about $8K in revenue per employee, based on $1M annual revenue and 123 employees.
How much funding has Genesis Therapeutics raised?
Genesis Therapeutics has raised $304.02M in total funding.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.